Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Brief Report: Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  • U S Kristoffersen
  • A M Lebech
  • J Gerstoft
  • B Hesse
  • C L Petersen
  • H Gutte
  • A Kjaer
View graph of relations
OBJECTIVE: The aim of the study was to determine the incidence of myocardial dysfunction in an HIV-infected population receiving state-of-the-art treatment. METHODS: Between April 2001 and July 2002, 91 HIV-infected patients had a radionuclide ventriculography performed with determination of right ventricular ejection fraction (RVEF) and left ventricular ejection fraction (LVEF), as well as measurement of brain natriuretic peptide (BNP). Between July 2005 and January 2007, 63 patients (69%) agreed to participate in a follow-up study with a mean follow-up of 4.5 years. RESULTS: All patients had normal LVEF at both examinations. A minimal increase in mean LVEF of 0.02 was observed at follow-up (P=0.01). At the initial visit, four patients [6%; 95% confidence interval (CI) 2-15%] had a reduced RVEF, and at follow-up two patients (3%; 95% CI 0-11%) had slightly reduced RVEF. No significant change in mean RVEF was found. No patients had increased BNP and no change in mean plasma BNP was found. CONCLUSIONS: HIV-related cardiomyopathy appears not to constitute a problem in closely monitored, well-treated HIV-infected patients. Compared with pre-highly active antiretroviral therapy (HAART) studies, it seems that the improvement in immunocompetency and viral load has removed the problem of HIV-related cardiomyopathy. Although HAART has been suggested as a possible new cause of cardiomyopathy, we did not find any evidence of this.
Original languageEnglish
JournalHIV Medicine
Volume9
Issue number3
Pages (from-to)180-6
Number of pages6
ISSN1464-2662
DOIs
Publication statusPublished - 2008

    Research areas

  • Adult, Antiretroviral Therapy, Highly Active, Cardiomyopathies, Female, Follow-Up Studies, HIV Infections, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Radionuclide Ventriculography, Radiopharmaceuticals, Stroke Volume, Technetium Tc 99m Aggregated Albumin, Ventricular Dysfunction, Left, Ventricular Dysfunction, Right, Viral Load

ID: 32508385